597 related articles for article (PubMed ID: 11402628)
21. Extract of Ocimum canum lowers blood glucose and facilitates insulin release by isolated pancreatic beta-islet cells.
Nyarko AK; Asare-Anane H; Ofosuhene M; Addy ME
Phytomedicine; 2002 May; 9(4):346-51. PubMed ID: 12120816
[TBL] [Abstract][Full Text] [Related]
22. Fasting plus prandial insulin supplements improve insulin secretory ability in NIDDM subjects.
Kawamori R; Bando K; Yamasaki Y; Kubota M; Watarai T; Iwama N; Shichiri M; Kamada T
Diabetes Care; 1989; 12(10):680-5. PubMed ID: 2515048
[TBL] [Abstract][Full Text] [Related]
23. The effect of glimepiride on pancreatic beta-cell function under hyperglycaemic clamp and hyperinsulinaemic, euglycaemic clamp conditions in non-insulin-dependent diabetes mellitus.
Clark HE; Matthews DR
Horm Metab Res; 1996 Sep; 28(9):445-50. PubMed ID: 8911981
[TBL] [Abstract][Full Text] [Related]
24. Assessment of beta-cell function during the oral glucose tolerance test by a minimal model of insulin secretion.
Cretti A; Lehtovirta M; Bonora E; Brunato B; Zenti MG; Tosi F; Caputo M; Caruso B; Groop LC; Muggeo M; Bonadonna RC
Eur J Clin Invest; 2001 May; 31(5):405-16. PubMed ID: 11380592
[TBL] [Abstract][Full Text] [Related]
25. The effects of obesity on the pharmacokinetics and pharmacodynamics of glipizide in patients with non-insulin-dependent diabetes mellitus.
Jaber LA; Ducharme MP; Halapy H
Ther Drug Monit; 1996 Feb; 18(1):6-13. PubMed ID: 8848822
[TBL] [Abstract][Full Text] [Related]
26. Prolonged sulfonylurea administration decreases insulin resistance and increases insulin secretion in non-insulin-dependent diabetes mellitus: evidence for improved insulin action at a postreceptor site in hepatic as well as extrahepatic tissues.
Mandarino LJ; Gerich JE
Diabetes Care; 1984; 7 Suppl 1():89-99. PubMed ID: 6376034
[TBL] [Abstract][Full Text] [Related]
27. Mode of action of ipomoea batatas (Caiapo) in type 2 diabetic patients.
Ludvik B; Waldhäusl W; Prager R; Kautzky-Willer A; Pacini G
Metabolism; 2003 Jul; 52(7):875-80. PubMed ID: 12870164
[TBL] [Abstract][Full Text] [Related]
28. Improved haemorrheological properties by Ginkgo biloba extract (Egb 761) in type 2 diabetes mellitus complicated with retinopathy.
Huang SY; Jeng C; Kao SC; Yu JJ; Liu DZ
Clin Nutr; 2004 Aug; 23(4):615-21. PubMed ID: 15297098
[TBL] [Abstract][Full Text] [Related]
29. C-peptide response to meal challenge in nondiabetic and diabetic adults living in Wadena, Minnesota.
Bushhouse SA; Goetz FC; Jacobs DR; Bender AP; French LR; Oestreich PG; Geisser MS
Diabetes Care; 1992 Oct; 15(10):1335-47. PubMed ID: 1425099
[TBL] [Abstract][Full Text] [Related]
30. Effects of repeated treatments with an extract of Ginkgo biloba (EGb 761), bilobalide and ginkgolide B on the electrical activity of pancreatic beta cells of normal or alloxan-diabetic mice: an ex vivo study with intracellular microelectrodes.
Vasseur M; Jean T; DeFeudis FV; Drieu K
Gen Pharmacol; 1994 Jan; 25(1):31-46. PubMed ID: 8026711
[TBL] [Abstract][Full Text] [Related]
31. Glucose tolerance and insulin response to glucose load before and after enzyme inducing therapy in subjects with glucose intolerance and patients with NIDDM having hyperinsulinemia or relative insulin deficiency.
Sotaniemi EA; Karvonen I
Diabetes Res; 1989 Jul; 11(3):131-9. PubMed ID: 2697484
[TBL] [Abstract][Full Text] [Related]
32. Antidiabetic effect of Symplocos cochinchinensis (Lour.) S. Moore. in type 2 diabetic rats.
Sunil C; Ignacimuthu S; Agastian P
J Ethnopharmacol; 2011 Mar; 134(2):298-304. PubMed ID: 21182925
[TBL] [Abstract][Full Text] [Related]
33. Beta-cell response to intravenous glucagon in African-American and Hispanic children with type 2 diabetes mellitus.
Taha DR; Castells S; Umpaichitra V; Bastian W; Banerji MA
J Pediatr Endocrinol Metab; 2002 Jan; 15(1):59-67. PubMed ID: 11822582
[TBL] [Abstract][Full Text] [Related]
34. Patients With Long-QT Syndrome Caused by Impaired
Hyltén-Cavallius L; Iepsen EW; Wewer Albrechtsen NJ; Svendstrup M; Lubberding AF; Hartmann B; Jespersen T; Linneberg A; Christiansen M; Vestergaard H; Pedersen O; Holst JJ; Kanters JK; Hansen T; Torekov SS
Circulation; 2017 May; 135(18):1705-1719. PubMed ID: 28235848
[TBL] [Abstract][Full Text] [Related]
35. Pharmacokinetic herb-disease-drug interactions: Effect of ginkgo biloba extract on the pharmacokinetics of pitavastatin, a substrate of Oatp1b2, in rats with non-alcoholic fatty liver disease.
Li Z; Tian S; Wu Z; Xu X; Lei L; Li Y; Wang B; Huang Y
J Ethnopharmacol; 2021 Nov; 280():114469. PubMed ID: 34329714
[TBL] [Abstract][Full Text] [Related]
36. Serum free C-peptide response to oral glucose loading as a parameter for the monitoring of pancreatic B-cell function in diabetic patients.
Hsieh SD; Kanazawa Y; Akanuma Y
Diabetes Res Clin Pract; 1985 Aug; 1(2):109-14. PubMed ID: 3915258
[TBL] [Abstract][Full Text] [Related]
37. [Associations of insulin resistance and pancreatic beta-cell function with plasma glucose level in type 2 diabetes].
Nian X; Sun G; Dou C; Hou H; Fan X; Yu H; Ma L; He B
Zhonghua Yi Xue Za Zhi; 2002 Jun; 82(11):732-5. PubMed ID: 12126540
[TBL] [Abstract][Full Text] [Related]
38. Small doses of subcutaneous insulin as a strategy for preventing slowly progressive beta-cell failure in islet cell antibody-positive patients with clinical features of NIDDM.
Kobayashi T; Nakanishi K; Murase T; Kosaka K
Diabetes; 1996 May; 45(5):622-6. PubMed ID: 8621013
[TBL] [Abstract][Full Text] [Related]
39. Changes in amylin and amylin-like peptide concentrations and beta-cell function in response to sulfonylurea or insulin therapy in NIDDM.
Rachman J; Payne MJ; Levy JC; Barrow BA; Holman RR; Turner RC
Diabetes Care; 1998 May; 21(5):810-6. PubMed ID: 9589246
[TBL] [Abstract][Full Text] [Related]
40. Plasma PAF acetylhydrolase in non-insulin dependent diabetes mellitus and obesity: effect of hyperinsulinemia and lovastatin treatment.
Kudolo GB; Bressler P; DeFronzo RA
J Lipid Mediat Cell Signal; 1997 Nov; 17(2):97-113. PubMed ID: 9459136
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
